ProShare Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $648K | Sell |
|
|||||
|
2018
Q2 | $521K | Buy |
|
|||||
|
2018
Q1 | $278K | Buy |
|
|||||
|
2017
Q4 | $110K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $94K | Sell |
|
|||||
|
2016
Q2 | $116K | Buy |
|
|||||
|
2016
Q1 | $110K | Sell |
|
|||||
|
2015
Q4 | $157K | Buy |
|
|||||
|
2015
Q3 | $163K | Sell |
|
|||||
|
2015
Q2 | $198K | Sell |
|
|||||
|
2015
Q1 | $255K | Buy |
|
|||||
|
2014
Q4 | $224K | Sell |
|
|||||
|
2014
Q3 | $220K | Sell |
|
|||||
|
2014
Q2 | $285K | Sell |
|
|||||
|
2014
Q1 | $1.39M | Buy |
|
|||||
|
2013
Q4 | $194K | Sell |
|
|||||
|
2013
Q3 | $425K | Buy |
|
|||||
|
2013
Q2 | $343K | Buy |
|